Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
1% Colloidal Oatmeal Balm for Atopic Dermatitis
NCT02691507Phase 2Completed
- Sponsor
- Johnson & Johnson
- Start
- Feb 2016
- Primary completion
- Apr 2016
- Modality
- Transdermal Patches, Hydrogel Systems, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of colloidal oatmeal in atopic dermatitis (AD), sponsored by Johnson & Johnson. Started Feb 2016; status: completed.
02
Drugs
colloidal oatmeal
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT02691507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02691507.